These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18304528)

  • 1. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
    Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
    Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
    Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts.
    Ji M; Shi Y; Lou H
    Biosci Trends; 2011; 5(5):192-7. PubMed ID: 22101374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
    Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
    Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effects of low-frequency ultrasound combined with adriamycin on human leukemia multidrug resistance cell line K562/A02].
    Meng QQ; Chen BA; Wu W; Shao ZY; Gao F; Zhao HH
    Ai Zheng; 2008 Nov; 27(11):1182-5. PubMed ID: 19000450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells.
    Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
    Oncol Lett; 2012 Feb; 3(2):485-489. PubMed ID: 22740937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
    Cui X; Zhou S; Xu H; Zhao T; Liu A; Guo X; Wang F
    Anticancer Drugs; 2009 Oct; 20(9):800-6. PubMed ID: 19606017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of triptolide on sensitivity of K562/A02 cell line to adriamycin].
    Hui LL; Xu WL; Chen QY; Zhu XL; Long LL; Xu Y; Qing R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):66-9. PubMed ID: 22391167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
    Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
    Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.
    Jiao L; Qiu Q; Liu B; Zhao T; Huang W; Qian H
    Bioorg Med Chem; 2014 Dec; 22(24):6857-66. PubMed ID: 25464884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells.
    Ohtani H; Ikegawa T; Honda Y; Kohyama N; Morimoto S; Shoyama Y; Juichi M; Naito M; Tsuruo T; Sawada Y
    Pharm Res; 2007 Oct; 24(10):1936-43. PubMed ID: 17492365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.